日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Does stringent cytoreduction improve survival in advanced proliferative chronic myelomonocytic leukemia?

严格的细胞减灭术能否提高晚期增殖性慢性粒单核细胞白血病患者的生存率?

Selimoglu-Buet, Dorothée; Chevret, Sylvie; Santini, Valeria; Thépot, Sylvain; Morabito, Margot; Adès, Lionel; Laplane, Lucie; Giagounidis, Aristoteles; Droin, Nathalie; Lübbert, Michael; Sapena, Rosa; Nimubona, Stanislas; Torregrosa-Diaz, Jose Miguel; Germing, Ulrich; Pelizzari, Anna Maria; Park, Sophie; Jaekel, Nadja; Metzgeroth, Georgia; Onida, Francesco; Paul, Franciane; Patriarca, Andrea; Stamatoullas, Aspasia; Götze, Katharina; Chermat, Fatiha; Platzbecker, Uwe; Fenaux, Pierre; Solary, Eric; Itzykson, Raphael

Lupuslike Manifestations in Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia

骨髓增生异常综合征和慢性粒单核细胞白血病中的狼疮样表现

Chauffier, Jeanne; Jachiet, Vincent; Battistella, Maxime; Romero, Pierre; Fenaux, Pierre; Zakine, Eve; Zhao, Lin Pierre; Mahévas, Thibault; Bouaziz, Jean-David; Hadjadj, Jerome; Amoura, Zahir; Mathian, Alexis; Breillat, Paul; Hirsch, Pierre; Bourguiba, Rim; De Voeght, Adrien; Grobost, Vincent; Begon, Edouard; Jandus, Peter; Brenaut, Emilie; Laumondais, Victoire; Fain, Olivier; Moguelet, Philippe; Mekinian, Arsene; Chasset, François

American College of Rheumatology Guidance Statement for Diagnosis and Management of VEXAS Developed by the International VEXAS Working Group Expert Panel

美国风湿病学会关于VEXAS诊断和治疗的指导声明,由国际VEXAS工作组专家组制定

Mekinian, Arsene; Georgin-Lavialle, Sophie; Ferrada, Marcela A; Savic, Sinisa; Koster, Matthew J; Kosmider, Olivier; Comont, Thibault; Heiblig, Mael; Arostegui, Juan I; Bosco, Annmarie; Bourguiba, Rim; Calvo, Katherine R; Cargo, Catherine; Cattaneo, Chiara; Chasset, François; Coelho, Henrique; Campochiaro, Corrado; Crisafulli, Francesca; Ducharme-Benard, Stephanie; Faria, Raquel; Franceschini, Franco; Frassi, Micol; Groarke, Emma M; Gurnari, Carmelo; Hakobyan, Yervand; Jamilloux, Yvan; Jurcut, Ciprian; Kirino, Yohei; Kulasekararaj, Austin; Kunimoto, Hiroyoshi; Madigan, Lauren M; Mann, Heřman F; Marvisi, Chiara; Milchert, Marcin; Morais, Sara; Sockel, Katja; Muratore, Francesco; Nakajima, Hideaki; Patnaik, Mrinal M; Regadas, Luísa; Robin, Marie; Rutgers, Abraham; Salvarani, Carlo; Sammel, Anthony M; Seebach, Joerg; Sujobert, Pierre; Tomelleri, Alessandro; Urbanski, Geoffrey; Vandergheynst, Frédéric; Vieira, Romana; Viswanatha, David S; Więsik-Szewczyk, Ewa; Diral, Elisa; Terrier, Benjamin; Patel, Bhavisha A; Fenaux, Pierre; Grayson, Peter C; Beck, David B

European Reference Networks - a flagship activity of the EU in the field of rare and complex diseases: from 2017 to 2025

欧洲参考网络——欧盟在罕见病和复杂疾病领域的一项旗舰活动:2017年至2025年

Graessner, Holm; Ripp, Sophie; Pereira, Alberto M; Schaefer, Franz; Mathijssen, Irene; Blay, Jean-Yves; Mulders, Peter F A; Evangelista, Teresinha; Ligtenberg, Marjolijn J L; Wilde, Arthur A M; Ladenstein, Ruth; Lohse, Ansgar W; Mosca, Marta; Swart, Joost Frans; Hernández, Francisco; Fenaux, Pierre; Dollfus, Hélène; Verloes, Alain; Wagner, Thomas; Bodemer, Christine; Wijnen, Rene; Scarpa, Maurizio; Jondeau, Guillaume; Tumienė, Birutė; Gallina, Sandra; Arzimanoglou, Alexis; Sangiorgi, Luca

Olutasidenib for mutated IDH1 acute myeloid leukemia: final five-year results from the phase 2 pivotal cohort

Olutasidenib治疗IDH1突变型急性髓系白血病:II期关键队列的五年最终结果

Cortes, Jorge; Curti, Antonio; Fenaux, Pierre; Jonas, Brian A; Krauter, Jürgen; Montesinos, Pau; Récher, Christian; Taussig, David C; Wang, Eunice S; Watts, Justin; Wei, Andrew; Yee, Karen Wl; Tian, Hua; Sheppard, Aaron; Marzac, Christophe; de Botton, Stephane

The ENHANCE-3 study: venetoclax and azacitidine plus magrolimab or placebo for untreated AML unfit for intensive therapy

ENHANCE-3 研究:维奈托克和阿扎胞苷联合马格罗利单抗或安慰剂治疗不适合强化治疗的初治急性髓系白血病

Daver, Naval; Vyas, Paresh; Huls, Gerwin; Döhner, Hartmut; Maury, Sébastien; Novak, Jan; Papayannidis, Cristina; Martínez Chamorro, Carmen; Montesinos, Pau; Niroula, Rabin; Fenaux, Pierre; Esteve, Jordi; Wu, Shang-Ju; De Voeght, Adrien; Mayer, Jiri; Valk, Peter J M; Johnson, Lisa; Dong, Mei; Liu, Ke; Kuwahara, Sowmya; Caldwell, Kenneth; Guru Murthy, Guru Subramanian

Reducing clinical trial eligibility barriers for patients with MDS: an icMDS position statement

降低MDS患者参与临床试验的门槛:icMDS立场声明

Borate, Uma; Pugh, Kelly; Waller, Allyson; Welkie, Rina Li; Huang, Ying; Bewersdorf, Jan Philipp; Stahl, Maximilian; DeZern, Amy E; Platzbecker, Uwe; Sekeres, Mikkael A; Wei, Andrew H; Buckstein, Rena J; Roboz, Gail J; Savona, Michael R; Loghavi, Sanam; Hasserjian, Robert P; Fenaux, Pierre; Sallman, David A; Hourigan, Christopher S; Della Porta, Matteo Giovanni; Nimer, Stephen; Little, Richard F; Santini, Valeria; Efficace, Fabio; Taylor, Justin; Garcia-Manero, Guillermo; Odenike, Olatoyosi; Kim, Tae Kon; Halene, Stephanie; Komrokji, Rami S; Griffiths, Elizabeth A; Greenberg, Peter L; Xu, Mina L; Xie, Zhuoer; Bejar, Rafael; Sanz, Guillermo F; Patnaik, Mrinal M; Figueroa, Maria; Carraway, Hetty E; Abdel-Wahab, Omar; Starczynowski, Daniel; Padron, Eric; Boultwood, Jacqueline; Gore, Steven; Daver, Naval G; Churpek, Jane E; Majeti, Ravindra; Bennett, John M; List, Alan F; Brunner, Andrew M; Zeidan, Amer M

Somatic mutations and DNA methylation identify a subgroup of poor prognosis within lower-risk myelodysplastic syndromes

体细胞突变和DNA甲基化可以识别出低风险骨髓增生异常综合征中预后不良的亚组。

Rombaut, David; Sandmann, Sarah; Tekath, Tobias; Crouch, Simon; de Graaf, Aniek O; Smith, Alexandra; Painter, Daniel; Kosmider, Olivier; Tobiasson, Magnus; Lennartsson, Andreas; van der Reijden, Bert A; Park, Sophie; D'Aveni, Maud; Slama, Borhane; Clappier, Emmanuelle; Fenaux, Pierre; Adès, Lionel; van de Loosdrecht, Arjan; Langemeijer, Saskia; Symeonidis, Argiris; Čermák, Jaroslav; Preudhomme, Claude; Savic, Aleksandar; Germing, Ulrich; Stauder, Reinhard; Bowen, David; van Marrewijk, Corine; Bernard, Elsa; de Witte, Theo; Varghese, Julian; Hellström-Lindberg, Eva; Dugas, Martin; Martens, Joost; Malcovati, Luca; Jansen, Joop H; Fontenay, Michaela

Long-term follow-up and combined Phase 2 results of eprenetapopt and azacitidine in patients with TP53 mutant MDS/AML

长期随访及eprenetapopt联合阿扎胞苷治疗TP53突变型MDS/AML患者的II期联合试验结果

Sallman, David A; Komrokji, Rami S; Dezern, Amy E; Sebert, Marie; Garcia-Manero, Guillermo; Rahmé, Ramy; Winer, Eric S; Lehmann-Che, Jacqueline; Roboz, Gail J; Madelaine, Isabelle; Sekeres, Mikkael A; Peterlin, Pierre; Chan, Onyee; Beyne-Rauzy, Odile; Kuykendall, Andrew; Recher, Christian; McLemore, Amy; Stamatoullas, Aspasia; Zhang, Ling; Willems, Lise; Mo, Qianxing; Raffoux, Emmanuel; Nardelli, Lisa; Berthon, Céline; Al Ali, Najla H; Quesnel, Bruno; Padron, Eric; Kantarjian, Hagop M; List, Alan F; Ades, Lionel; Lancet, Jeffrey E; Fenaux, Pierre; Cluzeau, Thomas

Inflammatory disorders in IDH-mutated myeloid neoplasms: Characteristics and response to IDH inhibitors

IDH突变型髓系肿瘤的炎症性疾病:特征及对IDH抑制剂的反应

Stammler, Romain; Chen, Peter; Debeaupuis, Orianne; Zhao, Lin-Pierre; Ruyer-Thompson, Mirabelle; Zakine, Eve; Rossignol, Julien; Goldwirt, Lauriane; Comont, Thibault; Heiblig, Maël; Adès, Lionel; Sebert, Marie; Allain, Jean-Sébastien; Campagne, Julien; Couturier, Marie-Anne; Cumin, Marina; Dalmas, Marie-Caroline; Denis, Guillaume; Devloo, Cécile; De Voeght, Adrien; Drevon, Louis; Duffau, Pierre; Georgin-Lavialle, Sophie; Gobert, Delphine; Kosmider, Olivier; Rieux-Laucat, Frédéric; Abisror, Noémie; Lazaro, Estibaliz; Lopez, Jean-Guillaume; Maria, Alexandre; Mauhin, Wladimir; Merindol, Julie; Merlot, Claire; Mirault, Tristan; Pascal, Laurent; Perrin, François; Raffoux, Emmanuel; Rahme, Ramy; Roos-Weil, Damien; Terrier, Benjamin; Thoreau, Benjamin; Fain, Olivier; Fenaux, Pierre; Hirsch, Pierre; Jachiet, Vincent; Hadjadj, Jérôme; Mékinian, Arsène